Bangor Savings Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-200
Closed -$17.9K – 525
2023
Q4
$17.9K Hold
200
– – ﹤0.01% 382
2023
Q3
$14.6K Hold
200
– – ﹤0.01% 394
2023
Q2
$16.6K Hold
200
– – ﹤0.01% 394
2023
Q1
$15.2K Hold
200
– – ﹤0.01% 394
2022
Q4
$17K Hold
200
– – ﹤0.01% 391
2022
Q3
$16K Hold
200
– – ﹤0.01% 401
2022
Q2
$15K Buy
+200
New +$15K ﹤0.01% 397

Other funds holding XBI

Bangor Savings Bank's XBI Position: Q1 2024 in Review

Bangor Savings Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 200 shares — an estimated $17.9K sold.

Bangor Savings Bank first reported a position in XBI in Q2 2022 and held it in 7 quarters. The position peaked at $17.9K in Q4 2023. 782 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

  • Bangor Savings Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
  • Bangor Savings Bank sold 200 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $17.9K.
  • Bangor Savings Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 7 quarters.
  • Bangor Savings Bank's State Street SPDR S&P Biotech ETF position peaked at $17.9K in Q4 2023.
  • 782 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Bangor Savings Bank's 13F filing for Q1 2024, filed 11 Apr 2024.